Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biosimilar Growth Hormones Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The biosimilar growth hormones market has expanded quickly in recent years. It is projected to rise from $0.89 billion in 2025 to $0.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.1%. The expansion observed in the historic period can be attributed to the high cost of branded growth hormone therapies, increasing prevalence of growth hormone deficiency, rising pediatric growth disorder diagnoses, limited access to affordable treatment options, and dependence on hospital-based administration.
The biosimilar growth hormones market size is anticipated to expand rapidly over the next few years, projected to reach $1.46 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. The expansion during this forecast period stems from factors such as the patent expiry of branded growth hormones, increased approvals for biosimilars, the proliferation of self-administration therapies, heightened awareness of growth disorders, and escalating healthcare expenditure in developing markets. Notable trends for the forecast period include the growing adoption of economical biosimilar growth hormones, a rising need for pediatric and adult growth hormone treatments, an increasing preference for subcutaneous self-administration, the growth of online pharmacies and specialized clinics, and improved regulatory acceptance for biosimilars.
Get A Free Sample Report With In-Depth Market Insights:
Biosimilar Growth Hormones Market Growth Momentum: What Factors Are Shaping Demand?
The expansion of the global biosimilar growth hormone market is propelled by the rising incidence of growth hormone deficiency among children. This deficiency arises from damage to the pituitary gland or hypothalamus, potentially stemming from abnormal development before birth (congenital) or issues that emerge during or after birth (acquired). For example, data from September 2023, provided by Hormones Australia through the Endocrine Society of Australia (ESA) – an Australia-based national authority for the treatment of endocrine related conditions and disease – indicates that approximately 2 to 3 out of every 10,000 people are estimated to be affected by growth hormone deficiency. Consequently, the expanding population of children experiencing growth deficiencies is a key factor boosting the biosimilar growth hormones industry.
Biosimilar Growth Hormones Market Segment Landscape And Growth Outlook
The biosimilar growth hormones market covered in this report is segmented –
1) By Route Of Administration: Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics
Subsegments:
1) By Subcutaneous: Self-administration, Professional Administration
2) By Intramuscular: Pediatric Care, Adult Care
3) By Oral: Tablets, Capsules
Biosimilar Growth Hormones Market Trends Redefining Industry Growth
Leading companies in the biosimilar growth hormones market are innovating solutions, such as human growth hormone, to enhance the effectiveness and affordability of treatments for growth hormone deficiencies. Growth hormone solutions refer to medical interventions or supplements designed to stimulate or replace human growth hormone (HGH) in the body, addressing growth deficiencies or anti-aging needs. For example, in June 2023, Pfizer Inc., a US-based pharmaceutical company, and OPKO Health Inc., a US-based healthcare company, obtained US Food and Drug Administration (FDA) approval for NGENLA (somatrogon-ghla). This is a once-weekly injectable human growth hormone treatment specifically developed for pediatric patients experiencing growth hormone deficiency (GHD). This long-acting growth hormone therapy provides an alternative to daily injections, thereby improving adherence and convenience for both patients and caregivers. The approval stemmed from clinical studies that demonstrated its efficacy and safety, signifying a notable progression in growth hormone therapies.
Biosimilar Growth Hormones Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the biosimilar growth hormones market are Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation
View The Full Biosimilar Growth Hormones Market Report:
Biosimilar Growth Hormones Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the biosimilar growth hormone market in 2025. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
